Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Neos Therapeutics stock | $0.553
Own Neos Therapeutics stock in just a few minutes.
Neos Therapeutics, Inc is a drug manufacturers—specialty & generic business based in the US. Neos Therapeutics shares (NEOS) are listed on the NASDAQ and all prices are listed in US Dollars. Neos Therapeutics employs 213 staff and has a trailing 12-month revenue of around USD$57 million.
How to buy shares in Neos Therapeutics
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Neos Therapeutics. Find the stock by name or ticker symbol: NEOS. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Neos Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$0.553, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Neos Therapeutics, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Neos Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Neos Therapeutics share price
Use our graph to track the performance of NEOS stocks over time.Neos Therapeutics shares at a glance
Information last updated 2020-11-30.
| Latest market close | USD$0.553 |
|---|---|
| 52-week range | USD$0.45 - USD$1.98 |
| 50-day moving average | USD$0.6142 |
| 200-day moving average | USD$0.6748 |
| Wall St. target price | USD$5.5 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.783 |
Buy Neos Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Neos Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neos Therapeutics price performance over time
Historical closes compared with the close of $0.553 from 2020-12-09
| 1 week (2021-01-08) | -24.25% |
|---|---|
| 1 month (2020-12-16) | -18.32% |
| 3 months (2020-10-15) | 16.42% |
| 6 months (2020-07-15) | -12.91% |
| 1 year (2020-01-15) | -64.09% |
|---|---|
| 2 years (2019-01-15) | -76.06% |
| 3 years (2018-01-12) | 10.375 |
| 5 years (2016-01-15) | 9.68 |
Neos Therapeutics financials
| Revenue TTM | USD$57 million |
|---|---|
| Gross profit TTM | USD$39.5 million |
| Return on assets TTM | -10.71% |
| Return on equity TTM | 0% |
| Profit margin | -38.35% |
| Book value | $-0.032 |
| Market capitalisation | USD$29.9 million |
TTM: trailing 12 months
Shorting Neos Therapeutics shares
There are currently 2.1 million Neos Therapeutics shares held short by investors – that's known as Neos Therapeutics's "short interest". This figure is 1.8% down from 2.1 million last month.
There are a few different ways that this level of interest in shorting Neos Therapeutics shares can be evaluated.
Neos Therapeutics's "short interest ratio" (SIR)
Neos Therapeutics's "short interest ratio" (SIR) is the quantity of Neos Therapeutics shares currently shorted divided by the average quantity of Neos Therapeutics shares traded daily (recently around 1.6 million). Neos Therapeutics's SIR currently stands at 1.3. In other words for every 100,000 Neos Therapeutics shares traded daily on the market, roughly 1300 shares are currently held short.
However Neos Therapeutics's short interest can also be evaluated against the total number of Neos Therapeutics shares, or, against the total number of tradable Neos Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Neos Therapeutics's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Neos Therapeutics shares in existence, roughly 40 shares are currently held short) or 0.0425% of the tradable shares (for every 100,000 tradable Neos Therapeutics shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Neos Therapeutics.
Find out more about how you can short Neos Therapeutics stock.
Neos Therapeutics share dividends
We're not expecting Neos Therapeutics to pay a dividend over the next 12 months.
Neos Therapeutics share price volatility
Over the last 12 months, Neos Therapeutics's shares have ranged in value from as little as $0.45 up to $1.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neos Therapeutics's is 1.7294. This would suggest that Neos Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Neos Therapeutics overview
Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technology platform. Its products are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets Adzenys XR-ODT amphetamine for the treatment of ADHD; Cotempla XR-ODT methylphenidate to treat ADHD; Adzenys ER amphetamine for the treatment of ADHD; and generic Tussionex, a hydrocodone and chlorpheniramine polistirex XR oral suspension for cough and upper respiratory symptoms of a cold. It also offers NT0502, a clinical-stage product candidate that has completed Phase I pilot pharmacokinetic trial for the treatment of neurological conditions associated with excessive salivation and drooling to reduce chronic sialorrhea in patients. The company was incorporated in 2009 and is headquartered in Grand Prairie, Texas.
Frequently asked questions
More guides on Finder
-
How to buy Gold Royalty Corp (GROY) stock when it goes public
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
-
How to buy Bustle Digital Group (NEOS.US) stock when it goes public
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
-
How to buy Lucid Motors (NEOS.US) stock when it goes public
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
-
How to buy HF Foods Group stock | $7.55
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
-
How to buy Hannon Armstrong Sustainable Infrastructure Capital stock | $69.54
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
-
How to buy Griffin Industrial Realty stock | $65.9
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
-
How to buy FS Bancorp stock | $59.24
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
-
How to buy First Northwest Bancorp stock | $16.66
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
-
How to buy First National Corporation stock | $17.74
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
-
How to buy Farmers National Banc stock | $13.88
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
Ask an Expert